The Safety Profile of Same-Day Outpatient Total Ankle Arthroplasty

• Published in: The Journal of foot and ankle surgery 2022-01, Vol.61 (1), p.123-126
• Main Authors: Langan, Travis M., Rushing, Calvin J., McKenna, Bryon J., Berlet, Gregory C., Hyer, Christopher F.
• Format: Article
• Language: English
• Subjects: ambulatory surgery center; Ankle - surgery; Ankle Joint - surgery; Arthroplasty, Replacement, Ankle - adverse effects; complications; Humans; outpatient; Outpatients; Reoperation; Retrospective Studies; total ankle arthroplasty; total ankle replacement
• ISSN: 1067-2516; 1542-2224
• DOI: 10.1053/j.jfas.2021.07.003

There has been significant change in the health care policy in the United States in recent years with an increasing focus on health care costs and patient satisfaction. One strategy of cost containment is to transition outpatient surgery away from high cost hospital environments. Total ankle arthroplasty has begun the evolution to outpatient settings; however, there is limited published literature on the results of outpatient total ankle arthroplasty (TAA). The purpose of the present study was to review the safety profile of same day outpatient TAA at an ambulatory surgery center. A review of consecutive patients who underwent same day outpatient TAA for end-stage ankle arthritis with a minimum of 12 months’ follow-up was performed. The primary outcomes assessed were the incidence of perioperative adverse medical events, hospital admissions related to the procedure, and postoperative complications (minor and major). Univariate analyses were performed. Fifty-one patients who underwent same-day TAA between June 2016 and July 2018 were included; mean follow-up was 20.7 months (± 7.6). The mean age at time of surgery was 56.5 years (± 7.2), with a mean body mass index of 30.4 (± 5.3). Overall, there were no perioperative adverse medical events or hospital admissions related to the procedure. Five minor complications (9.8%) and 7 major (13.7%) were recorded. Of the major complications, only 1 required TAA revision. Implant survivorship during the most recent follow-up was 98%. The present study suggests that TAA can be performed safely in an outpatient ambulatory setting. Additional comparative studies with larger TAA cohorts and patient reported outcomes are warranted.